Advertisement
Research ArticleCHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Use of an Anti-Vascular Endothelial Growth Factor Antibody in a Pharmacokinetic Strategy to Increase the Efficacy of Intraperitoneal Chemotherapy

Dhaval K. Shah, Beom Soo Shin, Jean Veith, Karoly Tóth, Ralph J. Bernacki and Joseph P. Balthasar
Journal of Pharmacology and Experimental Therapeutics May 2009, 329 (2) 580-591; DOI: https://doi.org/10.1124/jpet.108.149443
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Use of an Anti-Vascular Endothelial Growth Factor Antibody in a Pharmacokinetic Strategy to Increase the Efficacy of Intraperitoneal Chemotherapy

Dhaval K. Shah, Beom Soo Shin, Jean Veith, Karoly Tóth, Ralph J. Bernacki and Joseph P. Balthasar
Journal of Pharmacology and Experimental Therapeutics May 1, 2009, 329 (2) 580-591; DOI: https://doi.org/10.1124/jpet.108.149443
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement